Synthomer PLC (LSE:SYNT) - Share price


Stock Report

Synthomer PLC SYNT

Last Price
GBX459.80

Day Change
-6.20|-1.33%

As of 26/02/2021
17:47:37 GMT | GBX
Minimum 15 Minutes Delay.

Last Close466.00p
Day Range455.60 - 467.80
Mkt Cap1.98Bil
52-Wk Range182.30 - 510.10
Yield %0.65
ISINGB0009887422
Volume1,407,085
P/E85.47
P/S0.01
P/CF0.12

Share Price

Total Returns 25/02/2021

 Chg (%)  
More ...
Synthomer PLC10.48 
FTSE 100 TR GBP1.58
 
Financials
201720182019
More ...
Income Statement
Turnover1,480.201,618.901,459.10
Operating Profit107.26122.50116.20
Net Profit74.80103.3085.60
Reported EPS20.1627.3021.40
Balance Sheet
Current Assets443.80471.70421.00
Non Current Assets750.10812.70838.40
Total Assets1,200.701,284.401,259.40
Current Liabilities395.00386.30298.30
Total Liabilities---
Total Equity406.20485.00670.50
Cash Flow
Operating Cash Flow157.80120.40163.00
Net Change in Cash10.709.2024.70

Regulatory News

DateAuthor Headline
24/02/2021James Gard Stock of the Week: All Posts
Every week we ask our Twitter followers which stocks we should write about - previous winners include Tesla, Amazon, Sony and Beyond Meat
09/02/2021James Gard Top FTSE Dividend Paying Stocks
UPDATED February 2021: Yields have pushed back up again after January's stock market pullback, while Glaxo had announced big changes to its dividend policy
24/11/2020Damien Conover Covid Vaccine Breakthrough: the Morningstar View
Morningstar analyst Damien Conover looks in detail at the latest vaccine developments from AstraZeneca and Pfizer/BioNTech
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
23/12/2020PurchaseMs. Caroline Johnstone440.0411,13649,003.00
10/11/2020DMr. Calum Grigor MacLean413.776,87328,438.00
06/05/2020DMr. Calum Grigor MacLean270.201,2603,405.00
06/05/2020Exercise of OptionMr. Calum Grigor MacLean0.0017,3160.00

Company Profile

Synthomer PLC is a specialty chemicals company. It supplies a variety of chemicals including latex and adhesives which are used in a wide range of markets such as construction, coatings, textiles, paper, and healthcare. The company’s products include styrene butadiene rubber used to make coated paper, packaging, bindings for carpet, foam mattresses, pillows, and shoes, and nitrile butadiene latex used to make medical gloves, and catheters, among others. The company organizes itself into four segments: performance elastomers, functional solutions, industrial specialties, and acrylate monomers. A vast majority of the company’s revenue is generated by the performance elastomers and functional solutions segments combined, and roughly half of the company’s revenue is earned in Europe.

Sector

Specialty Chemicals

Index

FTSE 250 , FTSE 350 , FTSE All Share

Next Event 04/03/2021

Final Results
Ratios
Comp
More ...
PER (E)79.63
Div Yld (E)0.70
PEG (E)0.00
ROCE11.55
Op Mrgn0.08
EPS Grwth-0.10
Dividends
PreviousLatest
More ...
Record Date04/10/1923/10/20
Ex-Div03/10/1922/10/20
Paid05/11/1910/11/20
Amnt4.003.00
Directors
More ...
Non-Executive DirectorDato Hau Hian Lee
Non-Executive Director, Senior Independent DirectorMr. Brendan Connolly
Executive Director, Group Chief Executive OfficerMr. Calum Grigor MacLean
Non-Executive DirectorThe Honourable Alexander Gordon Catto
Non-Executive DirectorDr. Just Jansz
Non-Executive Director, ChairmanMs. Caroline Johnstone
Executive Director, Chief Financial OfficerMr. Steve Bennett
Non-Executive DirectorMs. Holly Van Deursen
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.